Creative Medical Technology Holdings Inc (CELZ)

[Boersi]

https://www.facebook.com/CreativeMedicalTechnologyHoldings/


In January 2021, we filed an investigational new drug (IND) application with the FDA for our ImmCelz treatment of Stroke. Subsequent to the filing, we received a confirmation from the FDA that they had received our IND application and issued an IND application number. In March 2021, the FDA submitted questions and recommendations on our IND protocol. We provided answers to the questions, incorporated the FDA's recommendations into our protocol and re-submitted the updated protocol to the FDA. We are now waiting for the FDA to get back to us with any additional questions or recommendations. From our experience this is customary.